Will Moller is a Clinical Genomics Director and product manager at PierianDx heading up validation and various professional services PierianDx offers to clients. Prior to PierianDx, Moller acted as Entrepreneur-in-residence at Nidus Partners, wherein he identified and evaluated promising new technologies in their infancy and assisted in building start-up companies surrounding the research. He has his Masters in Biology from Stanford University where he worked in a population genetics laboratory working closely with Sanger sequencing. Moller brings a wealth of experience validating NGS assays and acting as the scientific leadership with customers during the implementation process ensuring a seamless integration of the native client programs to the PierianDx Clinical Genomics Workspace (CGW). He has personally validated more than fifteen assays, worked on twenty-seven successful customer assay deployments, and personally lead teams working through the implementation of eighteen new PierianDx clients.